Biotech Stocks Q1 2025 Recap: Winners And Underperformers
Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
TMCnet11h
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
The new study in animal models will investigate whether “initiated” cells, harboring a mutant RAS oncogene, can be eliminated with LB-100. If successful, LB-100 could have a significant role in the ...
24/7 Wall St.2h
Why Johnson & Johnson (JNJ), United Health (UNH) And Procter & Gamble (PG) Are Holding the S&P 500 From Dropping More
Traditional defensive stocks Johnson & Johnson, United Health, and Procter & Gamble are all up and helping to keep the S&P ...
Nikkei plunges, Yen strength in continued risk-off mode amid countdown to “Liberation Day”
- Nikkei plunged as much as 4%, more than Wall St’s Friday losses, while Yen gained against all-comers amid general risk-off ...
Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the National Kidney Foundation Spring Clinical Meetings 2025
Travere's late-breaking oral presentation at NKF details partial and complete proteinuria remission data from the DUPLEX Study of FILSPARI in FSGS ...
Corebridge Financial Inc. Lowers Stock Position in Rocket Lab USA, Inc. (NASDAQ:RKLB)
Corebridge Financial Inc. cut its holdings in Rocket Lab USA, Inc. (NASDAQ:RKLB – Free Report) by 7.0% during the fourth ...